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Abstract
This study examined whether neighborhood social environment was related to patterns of 
adherence to oral hypoglycemic agents among primary care patients with type 2 diabetes mellitus. 
Residents in neighborhoods with high social affluence, high residential stability and high 
neighborhood advantage compared to residents in neighborhoods with one or no high features 
present, were significantly more likely to have an adherent pattern compared to a nonadherent 
pattern. Neighborhood social environment may influence patterns of adherence. Reliance on a 
multi-level contextual framework, extending beyond the individual, to promote diabetic self-
management activities may be essential for notable public health improvements.
Keywords
primary health care; type 2 diabetes; neighborhood social environment; medication adherence
Introduction
Despite the development of effective pharmacological therapy to prevent both 
macrovascular and microvascular complications and adverse events1-4 diabetes control 
remains sub-optimal.5-7 Poor adherence to recommended regimens is a factor in preventable 
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morbidity and mortality in diabetic patients.8,9 While individual characteristics are important 
contributors to medication adherence, much of the observed variation in adherence rates 
remains unexplained by these factors.10-12 Neighborhood environment may shape 
medication adherence through many factors such as socioeconomic resources, perceptions, 
expectations and beliefs. Individuals living in the same neighborhood may be more similar 
to each other than persons living in other neighborhoods because they share common social, 
economic, systemic, and lifestyle characteristics. Thus there may be common health 
behaviors that persist over and above individual variation and relate to living 
environment.13,14 The assessment of this collective phenomenon is needed to fully elucidate 
and understand adherence behaviors. However, little empirical knowledge exists about the 
nature and size of these collective or contextual neighborhood level effects on health 
behaviors such as medication adherence.15
Neighborhood social environment is an important construct in discerning how neighborhood 
contextual effects influence health behavior.16 With a movement to examine neighborhood 
effects beyond the influence of poverty, a focus on social characteristics, organization and 
culture in relation to behaviors and outcomes has become essential.17 The concepts of social 
affluence, neighborhood advantage and residential stability, derived from the work of 
Sampson et al.,18-20 have been the subject of much research and have been established as 
important explanatory factors in understanding the role of neighborhood social environment 
in health.21-23 These measures tap into both the influence of poverty as well as social 
mechanisms and processes hypothesized to link neighborhood environment to health. We 
seek to understand whether these constructs are related to medication adherence, a critical 
predictor of prognostic outcomes particularly for patients with diabetes. Our conceptual 
framework, shown in Figure 1, depicts the key constructs assessed in this study relating key 
features of the neighborhood social environment to patterns of adherence over time.
Prior work has found that neighborhood residence is associated with medication 
adherence13,24,25 and other self-care behaviors,26-28 even when controlling for individual 
characteristics. However, these studies have been limited by their cross-sectional designs, 
reliance on subjective adherence assessments and/or lack of a representative sampling frame 
due to regional variations in culture, context and available resources. Few identified studies 
investigated this relationship among diabetic patients, a population for whom the 
environment may have a particularly salient role. Our work extends current findings by 
employing a longitudinal study design to examine adherence with medication regimens as 
assessed by an objective and time-varying measure of adherence among a diverse sample of 
primary care patients with diabetes. Demonstrating a relationship between features of 
neighborhood social environment and patterns of adherence to oral hypoglycemic agents 
will set the stage for interventions targeting resources for persons and neighborhoods most at 
risk for poor health.
Within a prospective randomized controlled trial we sought to investigate whether indicators 
of neighborhood social environment (social affluence, neighborhood advantage and 
residential stability) would be associated with patterns of adherence to oral hypoglycemic 
agents. Our aim was to examine whether residents in neighborhoods with high social 
affluence, high neighborhood advantage, and/or high residential stability would be more 
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likely to have a pattern of adherence or increasing adherence over time. We hypothesized 
that residents in neighborhoods with two or three features present (high social affluence, 
high neighborhood advantage and high residential stability) would be more likely to have a 
pattern of adherence or a pattern of increasing adherence than residents in neighborhoods 
with one or none of these features present. To our knowledge, this is the first investigation to 
examine social affluence, neighborhood advantage and residential stability in relation to 
longitudinal patterns of adherence among primary care patients with diabetes.
Methods
Recruitment
The randomized controlled trial, A Brief Intervention to Improve Adherence through 
Integrated Management of Type 2 Diabetes Mellitus and Depression Treatment, was 
designed to assess whether an integrated care intervention in primary care improved glucose 
control and depressive symptoms in type 2 diabetes mellitus (type 2 DM).29 In all, 180 
patients were recruited from three primary care practices in Philadelphia, Pennsylvania and 
were randomly assigned to the intervention or usual care. Patients with a diagnosis of type 2 
DM and a prescription for an oral hypoglycemic agent within the past year were identified 
through electronic medical records from April 2010 to April 2011. Patients with an 
upcoming appointment were approached for additional screening. Eligibility criteria were: 
1) aged 30 years and older; 2) a diagnosis of type 2 DM; and 3) a current prescription for an 
oral hypoglycemic agent. Exclusion criteria were: 1) inability to give informed consent; 2) 
significant cognitive impairment at baseline (Mini-Mental State Examination (MMSE) 
<21);30 3) residence in a care facility that provides medications on schedule; and 4) 
unwillingness or inability to use the Medication Event Monitoring System (MEMS). The 
study protocol was approved by the University of Pennsylvania, Perelman School of 
Medicine Institutional Review Board. The intervention is described in detail elsewhere.29
Study Design
The trial was conducted in two phases: the run-in phase and the randomized controlled trial 
phase. The first phase of this trial consisted of a 2-week run-in phase to obtain pre-
intervention adherence data for all patients. Baseline demographics and glycated 
hemoglobin (HbA1c) assays to measure glycemic control were also collected at this time. 
Phase 2 of the study, where patients were randomized to the integrated care intervention or 
usual care, commenced after the 2-week run-in phase and occurred over 12 weeks.
Intervention
Integrated care managers worked with patients individually in the intervention group to offer 
education, guideline-based treatment recommendations, and monitor adherence and clinical 
status in collaboration with physicians. The integrated care manager addressed factors 
involved in adherence to oral hypoglycemic agents. The patient-level factors resulting in 
nonadherence included depression, chronic medical conditions, function, cognition, social 
support, cost of medications, side effects, and past experiences with medications. We chose 
this multi-faceted approach because education alone has not been found to be effective for 
improving adherence.31
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The intervention was presented to patients as a supplement to, rather than a replacement for, 
existing primary care treatment. Over a three month period participants had three 30-minute 
in person sessions (baseline, 6 weeks and 12 weeks) and two 15-minute telephone 
monitoring contacts. Integrated care managers were two research coordinators (one Master's 
level and one bachelor's level) who administered all intervention activities. The integrated 
care managers received training on pharmacotherapy for type 2 DM management during 
weekly clinical sessions with the principal investigator prior to trial initiation.
Usual Care
Patients in the usual care group underwent the same assessments at the same time points 
(baseline, 6, and 12 weeks) as the patients in the integrated care intervention. Research 
assistants conducted all assessments in-person and were blinded to patients’ randomization 
status.
Measurement Strategy
Patient Characteristics—Potential study patients were screened for cognitive 
impairment using the MMSE, a short standardized mental status examination widely 
employed for clinical and research purposes.32 At baseline, sociodemographic 
characteristics were assessed using standard questions. Address data was obtained for 
participants at baseline. Electronic monitoring data obtained from the MEMS Caps were 
used to measure adherence to oral hypoglycemic agents. Adherence was assessed as the 
proportion of medication MEMS cap openings in a given week relative to the prescribed 
doses for the week. Blood glycemic control was assessed at baseline and 12 weeks in 
accordance with American Diabetes Association Guidelines.33 The in2it A1C Analyzer 
provides point of care testing and was used to obtain glycated hemoglobin (HbA1c) assays. 
This device has acceptable precision and agreement in comparison with laboratory 
services 34.
Neighborhood Social Environment—Individual patient residential data was geo-coded 
at the tract level and then was merged with 2010 tract-level Census data. Factor analysis was 
conducted on 13 variables as done in prior work by Sampson et al.18-20 and others to assess 
key constructs of the social environment: social affluence, neighborhood advantage and 
residential stability.12,18,21-23,35 Factor analysis examines the nature of the relationships 
between variables by identifying the smallest number of factors explaining composites of 
the observed variables. To decrease collinearity between resulting factors we required that 
variables loaded above 0.55 on a single factor. All 13 variables loaded above 0.55 on single 
factor resulting in three single composite factors/variables. Conventional diagnostics such as 
scree plots also confirmed these three identified factors. These factors represented constructs 
of neighborhood social environment: social affluence, neighborhood advantage, and 
residential stability. Social affluence was derived from five variables: percent of households 
with resident/room ratio greater than 1 (factor loading = 0.57), percent of female-headed 
households (0.84), percent unemployed (0.77), percent of people below the poverty line 
(0.87), and percent of people receiving public assistance (0.73). Neighborhood advantage 
was derived from three variables: percent of residents with at least a bachelor's degree 
(0.87), percent of people in professional occupations (0.75), and percent of people with a 
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household income greater than $75,000 (0.67). Finally, residential stability was derived from 
two variables: the percent of house owners (0.86) and the percent of residents living at the 
same address over 5 years (0.86). Factor scores for neighborhood social environment (social 
affluence, neighborhood advantage and residential stability) were dichotomized as high or 
low based on the sample median.
Analysis—This analysis was conducted employing classifications of patients into patterns 
of adherence to oral hypoglycemic agents, as per our prior work.36 In brief, we employed 
general growth curve mixture models (GGCMM)37-43 to generate estimated posterior 
probabilities of unobserved class membership for each patient. This seminal approach 
improves precision by accounting for both intervention effects and baseline covariates on 
adherence over time. Longitudinal patterns of adherence to oral hypoglycemic agents were 
created by classifying patients based on the largest posterior probability of membership 
across the classes. The resulting categorical variable, patterns of adherence to oral 
hypoglycemic agents (adherent, increasing adherence, and nonadherent), was employed as 
the dependent variable for this analysis.
Multinomial logistic regression related neighborhood social environment (social affluence, 
neighborhood advantage and residential stability) to patterns of adherence to oral 
hypoglycemic agents. Results are presented in the form of odds ratios and 95% confidence 
intervals. Neighborhood social environment was assessed categorically. Consistent with 
prior work, the model included terms to adjust for age, ethnicity, gender, educational 
attainment, financial status, employment, frequency of medication administration, number of 
medical conditions, cognitive status, practice, baseline HbA1c, and intervention condition.44 
We set α at 0.05, recognizing that tests of statistical significance are approximations that 
serve as aids to inference. The GGCMM was fitted using Mplus version 7 (Muthén & 
Muthén) 45 and other analyses were conducted in STATA version 12 for Windows (STATA 
Corporation, College Station, TX).
Results
Study sample
The CONSORT flow diagram for the Brief Intervention to Improve Adherence through 
Integrated Management of Type 2 Diabetes Mellitus and Depression Treatment trial has 
been published elsewhere.29 In brief, of 715 patients with type 2 DM identified by electronic 
medical records, 265 were eligible and were approached and 190 were enrolled (71.7% 
participation rate). Consent was followed by a 2-week run-in phase in which adherence to 
medications was assessed. At the 2-week visit, 5 physicians had discontinued the 
antidepressant, 1 physician discontinued the oral hypoglycemic agent, and 2 patients were 
lost to follow-up. In all, 182 patients were randomized to the integrated care intervention or 
usual care. After randomization at the 2-week meeting, 2 patients in the integrated care 
intervention were lost to follow-up leaving 180 patients who completed the final study visit 
for our study sample.
In all, 179 patients had complete data on residential address and covariates of interest and 
were included in the present analysis. The mean age of our sample was 57.4 years (standard 
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deviation (s.d.) 9.5 years). One hundred and twenty-one (67.6%) of the patients were 
women. The self-identified ethnicity of patients was 65 white (36.3%), 101 African-
American (56.4%), 7 Hispanic (3.9%), and 6 (3.4%) who self-identified as ‘other.’ In all, 69 
patients (38.6%) were married, and 29 patients (16.2%) had less than a high school 
education. The mean number of medical conditions was 7.3 (s.d. 2.4) and the mean MMSE 
score was 28.2 (s.d. 2.3). Social affluence, residential stability, and neighborhood advantage 
stratified by median factor score as High and Low are depicted in Table 1.
Neighborhood social environment (residential stability, social affluence, and 
neighborhood advantage) and patterns of adherence to oral hypoglycemic agents
We examined the relationship between composite neighborhood characteristics and patterns 
of adherence to oral hypoglycemic agents (Table 2). The column of Table 2 labeled 
Adherent vs. Nonadherent provides odds ratios estimating the association of neighborhood 
social environment with patterns of adherence, comparing the adherent pattern to the 
nonadherent pattern. Compared to residents in neighborhoods with one or no high features 
present, residents in neighborhoods with high social affluence, high residential stability, and 
high neighborhood advantage were more likely to have an adherent pattern compared to a 
nonadherent pattern (adjusted odd ratio (OR)= 8.48, 95% confidence interval (CI) [1.71, 
42.02]). The column of Table 2 labeled Increasing Adherence vs. Nonadherent compares the 
increasing adherence pattern to the nonadherent pattern. Compared to residents in 
neighborhoods with one or no high features present, residents in neighborhoods with high 
social affluence, high residential stability, and high neighborhood advantage were more 
likely to have an increasing adherence pattern compared to a nonadherent pattern (adjusted 
OR= 12.91, 95% CI [2.20, 75.80]). There was not a significant relationship between 
neighborhoods with two features present and patterns of adherence.
Discussion
The principal finding of this study is that residents in neighborhoods with high social 
affluence, high residential stability, and high neighborhood advantage were much more 
likely to have an adherent pattern compared to a nonadherent pattern. Similarly, residents in 
neighborhoods with high social affluence, high residential stability, and high neighborhood 
advantage were much more likely to have an increasing adherence pattern compared to a 
nonadherent pattern. These results provide evidence that features of neighborhood social 
environment may be important contributors to patterns of adherence to oral hypoglycemic 
agents, a critical factor in treatment effectiveness and subsequent outcomes.
Before we discuss our findings, the results must be considered in the context of several 
potential study limitations. First, data was collected from three primary care sites whose 
patients may not be representative of other primary care practice settings. However, they 
were similar to other primary care practices in the region in terms of diversity and size. 
Second, it is important to note that all methods for assessing adherence have limitations. We 
utilized MEMS caps as our primary measure because they are an objective measure, have a 
low failure rate,46 and are more sensitive than other measures.47 Both groups (intervention 
and usual care) would experience any influence of MEMS caps on medication adherence 
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equally. Third, we solely examined the role of neighborhood social environment on 
behavioral patterns (medication adherence). Future research could incorporate other 
measures of neighborhood environment (e.g. physical environment: built environment, local 
food environment) as well as individual factors (physical health, psychosocial stress, and 
psychosocial resources) and health outcomes in order to delve deeper into the complex 
interplay of mediating or moderating pathways linking neighborhoods to health across time. 
Finally, we are constrained by the utilization of an administrative definition of 
neighborhoods (census tracts), which may not be the most meaningful level of aggregation. 
It is possible that assessment within a more respondent-derived neighborhood context may 
elicit the greatest explanatory power in understanding the role of neighborhood 
environment.48
Despite these limitations, our results are important to consider given that this study is one of 
the first examine the relationship between neighborhood social environment, as assessed by 
social affluence, residential stability, and neighborhood advantage, and patterns of 
adherence. A growing body of evidence has linked indicators of neighborhood social 
environment, namely measures of socioeconomic status with morbidity and mortality.49 
However, little research has examined more proximal mechanisms to health, health 
behaviors, which are critical precedents for understanding disease prognosis in diabetes. In 
our work, we characterize mechanisms shaping the link between neighborhood social 
environment and health21,22 demonstrating that the presence of multiple features (high 
social affluence, high residential stability, and high neighborhood advantage) may be critical 
in understanding adherence patterns. Our results support evidence that neighborhoods matter 
and furthermore help to inform and enhance future research on how neighborhoods matter.
While we found that residents in neighborhoods with three high features present were 
significantly more likely to have a pattern of adherence or a pattern of increasing adherence, 
we did not find that residents in neighborhoods with two features present were significantly 
more likely to have a pattern of adherence or a pattern of increasing adherence. This aligns 
with work demonstrating that accumulation of exposures to multiple contextual factors may 
explain the health impact of neighborhoods. While the presence of a few features is 
somewhat influential, the presence of multiple features for extended periods of time is 
associated with the greatest health impact.50 Because fewer neighborhood features may have 
only a modest effect, our study may not have been large enough to provide an adequate test 
of our hypothesis that residents in neighborhoods with two features present were 
significantly more likely to have a pattern of adherence or a pattern of increasing adherence 
than residents in neighborhoods with one or no features present.
Our findings are consistent with the work of Billmek et al. in which nonadherence to 
medications was examined in relation to neighborhood deprivation among persons with type 
2 DM. Billmek and colleagues examined the cross-sectional relationship of neighborhood 
deprivation, as assessed by the Neighborhood Socioeconomic Status Index comprised of 
census tract measures, and self-reported adherence. Their findings suggest that social 
environment as well as related costs may contribute to nonadherence.24 In our work we 
enrolled patients who already had filled prescriptions for oral hypoglycemic agents and we 
adjusted for individual financial status, thus minimizing the influence of cost on adherence 
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to medication regimens, and supporting evidence that neighborhood social environment and 
adherence may be linked by factors other than financial pressure. Our work is further 
delineated from prior work by a focus on features of neighborhood social environment 
derived from the work of Sampson et al.18-20 Our findings provide insight into the social 
mechanisms and process that link neighborhood environment to health. Furthermore, we 
used an objective measure of adherence, and our use of general growth curve mixture 
models allowed us to distinguish distinct patterns of adherence over time instead of 
assessing adherence through proportions at singular point(s) in time with no assessment of 
variation over time and group classification. Our findings extend prior work by 
demonstrating that features of the social environment are associated with longitudinal 
patterns of adherence as assessed by objective measures of medication adherence among 
primary care patients with type 2 DM.
Our results highlight the significance of features of the social environment in shaping 
patterns of adherence to oral hypoglycemic agents over time, over and above of the effects 
of individual characteristics. A framework through which we can characterize the 
underlying mechanisms relating neighborhood social environment to adherence has been 
established.51,52 Following this framework, a lack of social capital and/or cohesion may 
exist in neighborhoods with low social affluence, advantage, and stability.53 Such 
environments may lack a myriad of health promoting social processes such as social control 
over deviant health-related behavior and attitudes (e.g. over-eating). These environments 
may promote unhealthy behaviors through social norms,54 minimal levels of social trust 55 
and a lack of a supportive community environment.16 Furthermore, the character of daily 
routines, shaped by neighborhood environment (e.g. disorder), dictates the availability of 
temporal windows to engage in health promoting activities such as medication taking.56 
Such windows may be limited in more compromised neighborhoods. All these processes 
may be at work in shaping patterns of health behavior over time, particularly when multiple 
features are present cumulatively over the life course.57,58
This study is among the first to suggest that features of neighborhood social environment 
may influence medication adherence. While the distinct mechanisms for this association 
require further examination, this study adds to a growing body of evidence that patient's 
social environment influences behavioral patterns. While such contextual factors play a 
critical role in shaping health outcomes, they are seldom addressed or incorporated into 
treatment plans. As a result, patients who receive guideline concordant care may not achieve 
treatment targets due to factors related to their daily environmental context. Reliance on a 
multi-level contextual framework, extending beyond the individual, to promote diabetic self-
management activities may be essential for effective intervention deployment and notable 
public health improvements.59-61 Ongoing efforts to improve access and quality of care 
should be accompanied by initiatives to integrate the health care systems within community 
settings. Collaborative networks between healthcare systems and neighborhood communities 
are needed to foster effective adherence initiatives.
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Figure 1. 
Proposed conceptual model of indicators of neighborhood social environment and patterns 
of adherence to oral hypoglycemic agents. This model was adapted from the work of the 
Translating Research Into Action for Diabetes (TRIAD) study 26 and Carpiano RM 52
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Table 1
Social affluence, residential stability, and neighborhood advantage stratified by median factor score (High 
versus Low).
Neighborhood Indicators High (n=89) Low (n=90)
Social Affluence
Poverty (%), mean (s.d.) 13.52 (1.39) 35.60 (1.22)
Households with resident/room ratio > 1 (%), mean (s.d.) 1.00 (.12) 2.89(.29)
Female-headed households (%), mean (s.d.) 9.87 (.69) 29.71 (.75)
Unemployment rate (%), mean (s.d.) 7.1 (.39) 18.7 (.70)
Receiving public assistance (%), mean (s.d.) 2.22 (.18) 11.03 (.53)
Residential Stability
House owners (%), mean (s.d.) 60.39 (2.94) 51.77 (1.60)
Same address over 5 years (%), mean (s.d.) 61.49 (1.06) 57.96 (2.06)
Neighborhood Advantage
Residents with at least a bachelor's degree (%), mean (s.d.) 43.31 (2.21) 11.29 (.79)
Managerial/professional occupations (%), mean (s.d.) 13.85 (.66) 9.2 (.42)
Annual income greater than $75,000 (%), mean (s.d.) 38.70 (1.95) 12.24 (.81)
Note: s.d=standard deviation. Data obtained from 2010 U.S. Census and all measures are defined in accordance with these guidelines.
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Table 2
Multinomial logistic regression of neighborhood characteristics and three patterns of adherence (n= 179).
Adherent vs. Nonadherent 
OR [95% CI]
Increasing Adherence vs. Non 
adherence OR [95% CI]
Neighborhood characteristics
High social affluence, high residential stability, and high neighborhood 
advantage (n=41) 8.48
*
 [1.71, 42.02] 12.91
*
 [2.20, 75.80]
High social affluence and high neighborhood advantage (n=36) 2.44 [0.67, 8.86] 1.61 [0.35, 7.54]
High residential stability and high neighborhood advantage (n=10) 4.05 [0.28, 57.60] 1.86 [0.12, 28.54]
High social affluence and high residential stability (n=12) 1.78 [0.29, 10.75] 0.50 [0.05, 5.56]
One or fewer high features present: stability, affluence, or advantage 
(n=80)
1.00 1.00
Note: OR = odds ratio; CI = confidence interval
All estimates are adjusted for age, ethnicity, gender, educational attainment, financial status, employment, frequency of medication administration, 
number of medical conditions, cognitive status, practice, baseline glycated hemoglobin (HbA1c), depression, and intervention condition.
*
p< .05
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